Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolenium versus Seretide Diskus single-dose crossover equivalence study in asthma
2008-000193-21Phase 3Completed
- Sponsor
- ELPEN
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salmeterol + fluticasone in asthma and persistent asthma (3 arms), sponsored by ELPEN. Primary endpoint: 12-hour average FEV1. Started Jun 2008; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2008-000193-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000193-21.